Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15853316 | 0.87 | CYP2C19 (0.32) | CYP2C19TSHRTDP1 | |
| SCHEMBL18074158 | 0.85 | CYP2C19 (0.31) | CYP2C19 | |
| SCHEMBL823099 | 0.77 | CYP2C19 (0.38) | CYP2C19TSHRTDP1 | |
| SCHEMBL8571756 | 0.72 | — | — | |
| SCHEMBL16711191 | 0.72 | CYP2C19 (0.41) | CYP2C19 | |
| SCHEMBL16968108 | 0.72 | CYP2C19 (0.41) | CYP2C19 | |
| SCHEMBL8569644 | 0.72 | CA1 (0.38) | — | |
| SCHEMBL15277616 | 0.72 | CYP2C19 (0.35) | CYP2C19 | |
| SCHEMBL8573674 | 0.72 | TSHR (0.31) | TSHR | |
| SCHEMBL5677837 | 0.72 | CYP2C19 (0.35) | CYP2C19TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230147962-A1 | FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS | PHILOCHEM AG (CH) | 2023-05-11 | — | — | US | disclosed |
| US-6235956-B1 | ACETALIZATION OF KETONES WITH TETRAHYDROFURAN ALCOHOL | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230147962-A1 | FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS | FAP, FIBP, FGFR1 | CYP2C19 4762/4885TSHR 1472/4885TDP1 2981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.